BRCA1-deficient and -proficient mouse mammary tumor cells were treated with increasing concentrations of one compound in the absence or presence of a fixed concentration of the other compound and vice versa (Additional file 3: Fig. S3). This evidence concerns the gene BRCA1 and breast cancer.